您现在的位置是:首页>权威专家> 胃癌

Linus Ho, M.D., Ph.D.

Linus Ho, M.D., Ph.D. 助理教授

所在科室:内科

就职医院:MD安德森癌症中心

医生擅长:

在线咨询医学顾问 电话热线:400-666-7998

医生介绍

美国得克萨斯州休斯敦德克萨斯大学安德森癌症中心肿瘤医学科消化道(GI)肿瘤科副教授
教育经历:
1991年斯坦福大学医学院,美国加利福尼亚州斯坦福市,医学博士
1991年斯坦福大学医学院,美国加利福尼亚州斯坦福市,博士,癌症生物学
出版物:
  1. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin oncol 26 (21) :3487-95, 2008. PMID: 18640929
  2. Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin oncol 26 (21) :3496-502, 2008. PMID: 18640930
  3. Agarwal B, Correa AM, Ho L Survival in pancreatic carcinoma based on tumor size. Pancreas 36 (1) :e15-20, 2008. PMID: 18192868
  4. Cao D, Zhang Q, Wu LS, Salaria SN, Winter JW, Hruban RH, Goggins MS, Abbruzzese JL, Maitra A, Ho L Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases. Mod Pathol 20 (5) :570-8, 2007. PMID: 17396143
  5. Chun YS, Vauthey JN, Ribero D, Donadon M, Mullen JT, Eng C, Madoff DC, Chang DZ, Ho L, Kopetz S, Wei SH, Curley SA, Abdalla EK Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 11 (11) :1498-504; discussion 1504-5, 2007. PMID: 17849166
  6. Reyes-Gibby CC, Chan W, Abbruzzese JL, Xiong HQ, Ho L, Evans DB, Varadhachary G, Bhat S, Wolff RA, Crane C Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation. J Pain Symptom Manage 34 (3) :244-52, 2007. PMID: 17513082
  7. Ajani JA, Jiang Y, Faust J, Chang BB, Ho L, Yao JC, Rousey S, Dakhil S, Cherny RC, Craig C, Bleyer A A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma. Invest New Drugs 24 (4) :353-7, 2006. PMID: 16683077
  8. Kouvaraki MA, Korapati AL, Rassidakis GZ, Tian L, Zhang Q, Chiao P, Ho L, Evans DB, Claret FX Potential Role of Jun Activation Domain-Binding Protein 1 as a Negative Regulator of p27kip1 in Pancreatic Adenocarcinoma Cancer Res 66:8581-9, 2006. PMID: 16951171
  9. Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng C, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin oncol 24 (7) :1145-51, 2006. PMID: 16505434
  10. Ajani JA, Hecht JR, Ho L, Baker J, Oortgiesen M, Eduljee A, Michaeli D An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study. Cancer 106 (9) :1908-16. PMID: 16568451
  11. Overman MJ, Kazmi SM, Jhamb J, Lin E, Yao JC, Abbruzzese JL, Ho L, Ajani J, Phan AWeekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer. Cancer 116 (6) :1446-53. PMID: 20108336

相关报道资讯

视频科普

胃癌IV期伴有肝脏及肝胃间隙淋巴结转移患者赴日就医
胃癌IV期伴有肝脏及肝胃间隙淋巴结转移患者赴日就医

简介: 胃癌IV期伴有肝脏及肝胃间隙淋巴结转移,国内无标准方案,会诊得知这里胃癌5年生存率相比要高。习惯了家里的医院,还真不适应... 更多»

大肠癌伴肝转移患者赴日就医
大肠癌伴肝转移患者赴日就医

简介:大肠癌伴肝转移,本想国内治疗,但通过日ben癌研有明医院在线会诊,家人支持来院手术。非常顺利4小时完成切除和淋巴结清扫,第二... 更多»

胶质母细胞瘤和髓母细胞瘤患者赴日就医
胶质母细胞瘤和髓母细胞瘤患者赴日就医

简介: 你经历过绝望到希望吗?在国内先后被诊断为胶质母细胞瘤和髓母细胞瘤的患者。术后只做了脑部放疗,复发了。最后参加了日ben国... 更多»

肝癌患者日本国际就医案例
肝癌患者日本国际就医案例

简介: 肝癌,多年前在日ben癌研有明病院做的手术,这次来复查,结果很满意,但是还需3个月后再次复查,6月份再来,明日回国,感谢帮... 更多»

癌症患者的新方案来了!数十位国际专家带先进技术助力国内癌症患者
癌症患者的新方案来了!数十位国际专家带先进技术助力国内癌症患者

简介:癌症患者的新方案来了!数十位国际专家带先进技术助力国内癌症患者... 更多»

在线预约

绿色快速预约通道

Linus Ho, M.D., Ph.D.

请正确填写预约人和联系人等信息,提交需求成功后,请保持联系电话畅通,客服会在48小时内与您联系确认信息。客服热线:400-666-7998

Linus Ho, M.D., Ph.D. 助理教授

MD安德森癌症中心 内科

擅长

简介

美国得克萨斯州休斯敦德克萨斯大学安德森癌症中心肿瘤医学科消化道(GI)肿瘤科副教授
教育经历:
1991年斯坦福大学医学院,美国加利福尼亚州斯坦福市,医学博士
1991年斯坦福大学医学院,美国加利福尼亚州斯坦福市,博士,癌症生物学
出版物:
  1. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin oncol 26 (21) :3487-95, 2008. PMID: 18640929
  2. Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin oncol 26 (21) :3496-502, 2008. PMID: 18640930
  3. Agarwal B, Correa AM, Ho L Survival in pancreatic carcinoma based on tumor size. Pancreas 36 (1) :e15-20, 2008. PMID: 18192868
  4. Cao D, Zhang Q, Wu LS, Salaria SN, Winter JW, Hruban RH, Goggins MS, Abbruzzese JL, Maitra A, Ho L Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases. Mod Pathol 20 (5) :570-8, 2007. PMID: 17396143
  5. Chun YS, Vauthey JN, Ribero D, Donadon M, Mullen JT, Eng C, Madoff DC, Chang DZ, Ho L, Kopetz S, Wei SH, Curley SA, Abdalla EK Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 11 (11) :1498-504; discussion 1504-5, 2007. PMID: 17849166
  6. Reyes-Gibby CC, Chan W, Abbruzzese JL, Xiong HQ, Ho L, Evans DB, Varadhachary G, Bhat S, Wolff RA, Crane C Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation. J Pain Symptom Manage 34 (3) :244-52, 2007. PMID: 17513082
  7. Ajani JA, Jiang Y, Faust J, Chang BB, Ho L, Yao JC, Rousey S, Dakhil S, Cherny RC, Craig C, Bleyer A A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma. Invest New Drugs 24 (4) :353-7, 2006. PMID: 16683077
  8. Kouvaraki MA, Korapati AL, Rassidakis GZ, Tian L, Zhang Q, Chiao P, Ho L, Evans DB, Claret FX Potential Role of Jun Activation Domain-Binding Protein 1 as a Negative Regulator of p27kip1 in Pancreatic Adenocarcinoma Cancer Res 66:8581-9, 2006. PMID: 16951171
  9. Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng C, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin oncol 24 (7) :1145-51, 2006. PMID: 16505434
  10. Ajani JA, Hecht JR, Ho L, Baker J, Oortgiesen M, Eduljee A, Michaeli D An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study. Cancer 106 (9) :1908-16. PMID: 16568451
  11. Overman MJ, Kazmi SM, Jhamb J, Lin E, Yao JC, Abbruzzese JL, Ho L, Ajani J, Phan AWeekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer. Cancer 116 (6) :1446-53. PMID: 20108336

TA的文章视频